Literature DB >> 10758537

Palliation of Dysphagia of Esophageal Cancer by Endoscopic Lumen Restoration Techniques.

.   

Abstract

BACKGROUND: Cure of patients with esophageal cancer has remained rare over the past four decades. The overall five-year survival rate for squamous cell and adenocarcinoma of the esophagus currently is reported as 12% in whites and 8% in blacks. The five-year survival rate for localized disease at initial staging is only 26% for whites and 13% for blacks. With regional involvement, these rates are 11% and 7%, respectively.
METHODS: The author reviews the literature on optimal endoscopic lumen restoration techniques, including dilation, thermal laser and chemical ablation, photodynamic therapy, and stents. Procedures for pain relief and nutritional support are also presented.
RESULTS: Lumen restoration to relieve dysphagia and provide the opportunity for sustaining reasonable peroral nutrition is an essential element in the overall management. Nonsurgical lumen restoration procedures have much to offer for dysphagia palliation and are briefly reviewed in this presentation. The major options include ablation of intraluminal tumor mass by thermal laser, photodynamic laser, chemical ablation, peroral dilation, and placement of esophageal stents. Most patients require more than one palliative method to sustain lumen patency during the course of their disease.
CONCLUSIONS: Most patients with esophageal cancer will require palliation for the multiple problems that develop during their limited life span. The responsibility of the palliation therapist is to provide the patient with safe and cost-effective treatments that provide the best possible dysphagia relief.

Entities:  

Year:  1999        PMID: 10758537     DOI: 10.1177/107327489900600107

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  8 in total

Review 1.  Chemotherapy for upper gastrointestinal tumours.

Authors:  A L Thomas; K O'Byrne; W P Steward
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

2.  Management of total obstruction of the pharynx and upper esophagus.

Authors:  H Worth Boyce
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-12

3.  Stents for Esophageal Disease.

Authors:  Frank M. Moses; Roy K.H. Wong
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

4.  An Auxetic structure configured as oesophageal stent with potential to be used for palliative treatment of oesophageal cancer; development and in vitro mechanical analysis.

Authors:  Murtaza N Ali; Ihtesham Ur Rehman
Journal:  J Mater Sci Mater Med       Date:  2011-09-06       Impact factor: 3.896

5.  Self-expandable metal stents and trans-stent light delivery: are metal stents and photodynamic therapy compatible?

Authors:  Luo-Wei Wang; Li-Bo Li; Zhao-Shen Li; Yang K Chen; Fred W Hetzel; Zheng Huang
Journal:  Lasers Surg Med       Date:  2008-11       Impact factor: 4.025

Review 6.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

Review 7.  Palliative Endoscopic Therapy of Esophageal Cancer.

Authors:  Thomas Rabenstein
Journal:  Viszeralmedizin       Date:  2015-10-19

8.  Predictors of adverse events and early mortality after esophageal stent placement in a low resource setting: a series of 3823 patients in Kenya.

Authors:  Michael Mwachiro; Robert Parker; Justus Lando; Ian Simel; Nyail Chol; Sinkeet Ranketi; Robert Chepkwony; Linus Pyego; Caren Chepkirui; Winnie Chepkemoi; David Fleischer; Sanford Dawsey; Mark Topazian; Steve Burgert; Russell White
Journal:  Endosc Int Open       Date:  2022-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.